TMPRSS13 Inhibitors

Chemical inhibitors of TMPRSS13 encompass a variety of compounds that can impede the protein's function by binding to its active site or altering its structure. Camostat Mesilate and Gabexate Mesilate, both synthetic serine protease inhibitors, can directly inhibit TMPRSS13 by occupying its active site, thus preventing the protease from engaging with its substrates. The binding of these inhibitors mimics the natural substrate interaction, effectively blocking the catalytic activity of TMPRSS13. Nafamostat similarly can inhibit TMPRSS13 through binding to the serine residue essential for catalysis, resulting in a halt in proteolytic activity. Benzamidine, albeit simpler in structure, employs a competitive mechanism by mimicking substrates to obstruct the active site of TMPRSS13, thereby inhibiting its proteolytic cleavage function.

In a similar vein, AEBSF operates by covalently modifying the serine residue in the active site, leading to irreversible inhibition of TMPRSS13. Likewise, Aprotinin can form a stable complex with TMPRSS13, hindering substrate access by blocking the enzyme's active site. Leupeptin, a reversible serine protease inhibitor, achieves inhibition of TMPRSS13 by binding within the active site, preventing substrate cleavage. Although Pepstatin A is traditionally an aspartic protease inhibitor, it can also inhibit TMPRSS13 through a structural mimicry that blocks the protein's active site. E-64, while typically a cysteine protease inhibitor, can inhibit TMPRSS13 if the enzyme possesses a reactive cysteine residue near its active site, thereby leading to covalent and irreversible inhibition. SBTI can impede TMPRSS13 by directly obstructing the enzyme's active site, thereby precluding the access of physiological substrates. 3,4-Dichloroisocoumarin covalently modifies the serine hydroxyl group at the active site, which results in the inhibition of TMPRSS13's enzymatic activity. Lastly, Antipain's mechanism of inhibiting TMPRSS13 involves its interaction with the active site, which blocks substrate binding and inhibits protease function.